Category Archives: Uncategorized

Cell Applications, Inc. Strengthens Stem Cell Media Portfolio with Cardiomyocyte Differentiation Kit SAN DIEGO, Jan 27, 2017 — Cell Applications, Inc. introduces a specialized medium kit that differentiates Human Induced Pluripotent Stem Cells (HiPSC) into Cardiomyocytes (i-HCm).  The i-HCm Differentiation Medium Kit has everything needed: Differentiation, selection and maintenance media. Researchers can access this convenient, effective formula and protocol […]

SAN DIEGO, Nov 13, 2016 — Officials at Cell Applications, Inc. announce the launch of a unique model to study neural development, neurotoxicity, differentiation, electrophysiology and disease.  Human iPSC-Derived Neural Stem Cells (i-HNSC) are a homogeneous, self-renewing and multipotent population derived from Human Induced Pluripotent Stem Cells (HiPSC). Through partnership with leading stem cell company StemoniX, i-HNSC, and cells derived from them, […]

SAN DIEGO, Oct 26, 2016 — Today Cell Applications, Inc. announces the addition of two key Primary Cells of the nervous system: Rat Perineurial Fibroblasts (RPF) and Rat Schwann Cells (RSC), paired with their corresponding, optimized Rat Perineurial Fibroblast Media and  Schwann Cell Media. RPF form a connective tissue compartment of the peripheral nerve called the perineurium, which wraps around fascicles […]

CAI Introduces Human Trabecular Meshwork Cells SAN DIEGO, Sep 27, 2016 — Today Cell Applications, Inc. announces the addition of Human Trabecular Meshwork Cells to their Primary Eye Cells offering.  Located near the base of the cornea, HTMC regulate eye pressure by controlling drainage of fluid from the eye and into tubes that ultimately flow to the […]

Cell Applications, Inc. Launches Human Dendritic Cells and Media SAN DIEGO, Aug 26, 2016 — Today CAI introduced Human Dendritic Cells to their primary Blood Cell portfolio.  Isolated from peripheral blood, the cells (HDC-PB for short) arise from a distinct hematopoietic lineage and help regulate the immune system.  They mount adaptive immune responses to foreign antigens, […]

Human Blood and Cardiovascular Portfolio Expands at CAI SAN DIEGO, May 16, 2016 — Officials at Cell Applications, Inc. announce the addition of primary cells to their collection of Blood and Cardiac cells. Human Peripheral Blood Mononuclear Cells, or “PBMC” for short, provide a useful in vitro research tool for various aspects of pathology and biology. PBMC […]

Human CD34+ Hematopoietic Progenitor Stem Cells Launched SAN DIEGO, May 13, 2016 — Today Cell Applications, Inc. announced another extension of their stem cell offering, with the launch of Human Hematopoietic Stem Cells.  HHSC from Bone Marrow (HHSC-BM) or Liver (HHSC-L) contain CD34+ progenitor cells that differentiate into all the various blood cell types.  CD34 is […]

SAN DIEGO, Sep 3, 2015 — Basic researchers and pharmaceutical companies are using more & more neurons and optimized media to address normal physiology, pathology and nervous system disease.  Lying along the vertebral column by the spine, dorsal root ganglia are nerve cell body clusters containing afferent neurons that relay sensory information from the peripheral body […]

CAI Management System, with Regard to FDA 21 CFR Part 820 (cGMP), is Certified by UL SAN DIEGO, July 17, 2015 — UL Registrar LLC (Stroudsburg, Pennsylvania) has issued certificate of conformance # 15-172954-1 to Cell Applications, Inc., indicating CAI’s management system is certified by UL with regard to FDA 21 CFR Part 820, Current Good Manufacturing Practice for Medical Devices.  The certification […]

CAI Launches Serum- & Xeno-Free versions of its Human Mesenchymal Stem Cell Media SAN DIEGO, July 14, 2015 — To further optimize culture of Human Mesenchymal Stem Cells, Cell Applications, Inc. introduces Serum- and Xeno-Free versions to its line of HMSC Media. The optimized formulations reduce variation, increase reproducibility and facilitate expansion. For particular applications, HMSC […]